Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been referred through a fast-track ("2-week wait") or "Straight to Test" referral pathway because lower bowel cancer is suspected.
- People aged 18 years or older, of any gender.
- People referred through the fast-track pathway who do not have a history of inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).
- People whose general health and physical functioning falls within an acceptable range for the trial, as assessed by a doctor (confirm with trial site).
- People who have the ability to understand and agree to take part in the study.
Who may not be able to join:
- People referred outside of the standard fast-track or "Straight to Test" pathways for suspected lower bowel cancer, or those referred as an emergency.
- People under 18 years of age.
- People who are not well enough to undergo standard bowel investigations such as a camera test of the stomach, a camera test of the bowel, or a CT scan of the bowel.
- People who are unable to give their own consent, or who have chosen not to consent to taking part.
- People who currently have an untreated solid organ cancer (a cancer affecting organs such as the liver, kidney, or lungs).
- People who have a known diagnosis of inflammatory bowel disease.
- People who have a documented family history of inherited bowel cancer conditions (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohamed A Thaha, MBBS, FRCS, PhD, PGCe Hlt Econ, Queen Mary University of London
Phone: +442078828747
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive value of hPG80 to identify colorectal cancer and adenomatous polyp; Identification of Transposable Element (TE) signatures in plasma of colorectal cancer patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.